{"id":"https://openalex.org/W2942712784","doi":null,"title":"Adjuvant Ipilimumab After Resection May Benefit High-Risk Melanoma Patients","display_name":"Adjuvant Ipilimumab After Resection May Benefit High-Risk Melanoma Patients","alternate_titles":[],"publication_year":2015,"publication_date":"2015-05-04","ids":{"openalex":"https://openalex.org/W2942712784","mag":"2942712784"},"language":"en","primary_location":{"id":"mag:2942712784","doi":null,"is_oa":false,"landing_page_url":"https://www.oncotherapynetwork.com/skin-cancer-melanoma-targets/adjuvant-ipilimumab-after-resection-may-benefit-high-risk-melanoma-patients","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W2942712784"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083754415","display_name":"John Schieszer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John Schieszer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5083754415"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.8827999830245972,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11209999769926071,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.9869999885559082},{"id":"https://openalex.org/keywords/adjuvant-therapy","display_name":"adjuvant therapy","score":0.8769999742507935},{"id":"https://openalex.org/keywords/high-risk-melanoma","display_name":"high-risk melanoma","score":0.7689999938011169},{"id":"https://openalex.org/keywords/stage-iii-melanoma","display_name":"stage III melanoma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/recurrence-free-survival","display_name":"recurrence-free survival","score":0.871999979019165},{"id":"https://openalex.org/keywords/r0-resection","display_name":"R0 resection","score":0.625},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.6389999985694885}],"concepts":[{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.8836628198623657},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7769614458084106},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.625920295715332},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5908029675483704},{"id":"https://openalex.org/C159110652","wikidata":"https://www.wikidata.org/wiki/Q17078201","display_name":"Resection","level":2,"score":0.5140836834907532},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5000557899475098},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48303326964378357},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.27813196182250977},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.25794172286987305},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2293270230293274},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.11770859360694885}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2942712784","doi":null,"is_oa":false,"landing_page_url":"https://www.oncotherapynetwork.com/skin-cancer-melanoma-targets/adjuvant-ipilimumab-after-resection-may-benefit-high-risk-melanoma-patients","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4413760188","https://openalex.org/W2330621932","https://openalex.org/W2583641997","https://openalex.org/W2252985510","https://openalex.org/W2529373149","https://openalex.org/W2542888518","https://openalex.org/W2752227448","https://openalex.org/W2947700061","https://openalex.org/W2551622036","https://openalex.org/W3214653934"],"abstract_inverted_index":{"Adjuvant":[0],"ipilimumab":[1],"may":[2],"significantly":[3],"improve":[4],"recurrence-free":[5],"survival":[6],"for":[7],"patients":[8],"with":[9],"completely":[10],"resected,":[11],"high-risk":[12],"stage":[13],"III":[14,23],"melanoma,":[15],"according":[16],"to":[17],"a":[18],"new":[19],"randomized,":[20],"double-blind":[21],"phase":[22],"study":[24],"published":[25],"in":[26],"The":[27],"Lancet":[28],"Oncology.":[29]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2942712784","counts_by_year":[],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2019-05-09T00:00:00"}
